Fanconi anaemia: genetics, molecular biology, and cancer - implications for clinical management in children and adults.
AffiliationStem Cell and Leukaemia Proteomics Laboratory, University of Manchester, Manchester, UK
MetadataShow full item record
AbstractFanconi anaemia (FA) is an inherited disease with congenital and developmental abnormalities, cross-linker hypersensitivity and extreme cancer predisposition. With better understanding of the genetic and molecular basis of the disease, and improved clinical management, FA has been transformed from a life-limiting paediatric disease to an uncommon chronic condition that needs lifelong multidisciplinary management, and a paradigm condition for the understanding of the gene-environment interaction in the aetiology of congenital anomalies, haematopoiesis and cancer development. Here we review genetic, molecular and clinical aspects of FA, and discuss current controversies and future prospects.
CitationFanconi anaemia: genetics, molecular biology, and cancer - implications for clinical management in children and adults. 2015, 88 (1):13-24 Clin Genet
- Fanconi anaemia and leukaemia - clinical and molecular aspects.
- Authors: Tischkowitz M, Dokal I
- Issue date: 2004 Jul
- The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
- Authors: Myers K, Davies SM, Harris RE, Spunt SL, Smolarek T, Zimmerman S, McMasters R, Wagner L, Mueller R, Auerbach AD, Mehta PA
- Issue date: 2012 Mar
- The molecular and cellular biology of Fanconi anemia.
- Authors: Garcia-Higuera I, Kuang Y, D'Andrea AD
- Issue date: 1999 Mar
- Molecular pathogenesis and clinical management of Fanconi anemia.
- Authors: Kee Y, D'Andrea AD
- Issue date: 2012 Nov
- Fanconi anaemia: from a monogenic disease to sporadic cancer.
- Authors: Valeri A, Martínez S, Casado JA, Bueren JA
- Issue date: 2011 Apr